news
12-20-2012, 12:40 AM
The meeting with state health officials was aimed at determining how to strengthen rules governing compounding pharmacies in the wake of a national meningitis outbreak.http://rss.nytimes.com/c/34625/f/642562/s/26c57df3/mf.gif
http://da.feedsportal.com/r/151883674024/u/79/f/642562/c/34625/s/26c57df3/a2.img (http://da.feedsportal.com/r/151883674024/u/79/f/642562/c/34625/s/26c57df3/a2.htm)http://pi.feedsportal.com/r/151883674024/u/79/f/642562/c/34625/s/26c57df3/a2t.img
More... (http://www.nytimes.com/2012/12/20/health/fda-and-states-meet-about-regulation-of-drug-compounders.html?partner=rss&emc=rss)
http://da.feedsportal.com/r/151883674024/u/79/f/642562/c/34625/s/26c57df3/a2.img (http://da.feedsportal.com/r/151883674024/u/79/f/642562/c/34625/s/26c57df3/a2.htm)http://pi.feedsportal.com/r/151883674024/u/79/f/642562/c/34625/s/26c57df3/a2t.img
More... (http://www.nytimes.com/2012/12/20/health/fda-and-states-meet-about-regulation-of-drug-compounders.html?partner=rss&emc=rss)